Tara Moore, PhD, professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, RF1...
Vous n'êtes pas connecté
A team of researchers from NIH’s National Library of Medicine and National Cancer Institute developed an AI algorithm that could successfully identify relevant clinical trials for which a person is eligible and provide a summary that clearly explains how that person meets the criteria for study enrollment. The tool can help make it easier for both clinicians and patients to find and connect with the right clinical trial opportunities.
Tara Moore, PhD, professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, has been awarded a five-year, RF1...
A therapy discovered in Melbourne has moved into Phase 3 clinical trials, a milestone rarely reached by Australian research. Pfizer has begun studying...
A therapy discovered in Melbourne has moved into Phase 3 clinical trials, a milestone rarely reached by Australian research. Pfizer has begun studying...
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights...
As part of ongoing efforts to modernize operations and better serve the biomedical research and health information communities, the National Library...
A new study published in Nature Communications Medicine led by neurosurgery researchers Sima Mofakham, PhD, and Chuck Mikell, MD, of the Renaissance...
A new study published in Nature Communications Medicine led by neurosurgery researchers Sima Mofakham, PhD, and Chuck Mikell, MD, of the Renaissance...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...